Interim Monitoring for Futility in Clinical Trials with Two Co-primary Endpoints Using Prediction.

Asakura, Koko; Evans, Scott R; Hamasaki, Toshimitsu

Asakura, Koko; Evans, Scott R; Hamasaki, Toshimitsu.

Afiliación

Asakura K; Department of Data Science, National Cerebral and Cardiovascular Center, Osaka, Japan.
Evans SR; Department of Innovative Clinical Trials and Data Science, Osaka University Graduate School of Medicine, Osaka, Japan.
Hamasaki T; The Biostatistics Center and the Department of Biostatistics and Bioinformatics, George Washington University, Maryland, USA.

Stat Biopharm Res ; 12(2): 164-175, 2020.

Article en En | MEDLINE | ID: mdl-33042476

Palabras clave

Conditional Power; Group-sequential designs; Interim analyses; Predicted intervals; Predictive Power; Type I error

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Stat Biopharm Res Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google